|
|
||||||||
CUTTING EDGE |
The Wistar Institute, Philadelphia, PA 19104
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
chain (CD127) paired with the common
-chain have been shown to promote proliferation in response to low-affinity interactions with self-peptide:MHC complexes, particularly under conditions of lymphopenia (5, 6). However, 510% of the peripheral CD4+ T cells in normal mice are CD25+CD45RBlow cells that have been shown to have regulatory function (7). CD4+CD25+ regulatory T cells are generated as a result of high-affinity interactions with cognate self-peptide:MHC complexes in the thymus (8, 9). Although there is evidence that the sustained presence of CD4+ regulatory T cells may depend on the peripheral expression of self-Ag (10), how interactions with self-peptide:MHC complexes in the periphery contribute to maintaining or expanding the repertoire of CD4+CD25+ regulatory T cells has only begun to be examined (11, 12, 13). In this report, we have examined how CD4+CD25+ regulatory T cells respond to stimuli that could promote their expansion in the periphery using TS1 x HA28 mice. In TS1 x HA28 mice, thymocytes expressing the clonotypic 6.5 TCR undergo selection to become CD4+CD25+ regulatory T cells through interactions with the S1 peptide from influenza virus hemagglutinin expressed as a neo-self-peptide (8, 14). We show that 6.5highCD4+CD25+ regulatory T cells proliferate in response to S1 peptide in the periphery of HA28 mice. However, unlike conventional CD4+ T cells, CD4+CD25+ cells do not proliferate in response to lymphopenia in BALB/c mice (that lack S1 peptide). Their differing responsiveness to TCR vs lymphopenia-induced signals likely shapes the accumulation and activity of CD4+CD25+ regulatory T cells at sites where their selecting self-peptides are expressed.
| Materials and Methods |
|---|
|
|
|---|
TS1, TS1 x HA28, HA28, and TS1(SW) mice have been previously described (8, 14, 15). Recipient BALB/c (Harlan, Indianapolis, IN) and HA28 mice for adoptive transfers were left either nonmanipulated or were sublethally irradiated with 500 rad of gamma irradiation. All mice were maintained in sterile microisolators at The Wistar Institute animal facility and were used between 10 and 28 wk of age.
Flow cytometry
Single-cell suspensions of cells pooled from axillary, inguinal, brachial, and superficial cervical lymph nodes (LN)3 were stained with the following mAbs for flow-cytometric analysis: purified anti-CD16/32 (Fc block; 2.4G2; BD PharMingen, San Diego, CA), anti-CD4-allophycocyanin or anti-CD4-FITC (L3T4; BD PharMingen), anti-CD25-PE (PC61; BD PharMingen), anti-CD25-biotin or anti-CD25-FITC (7D4; BD PharMingen), anti-V
8.3-biotin (KT50; BD PharMingen), anti-CD127-PE (SB/14; BD PharMingen; or A7R34; eBioscience, San Diego, CA), and 6.5-biotin (15). Streptavidin-Red670 (Invitrogen, Carlsbad, CA) was used to detect biotinylated reagents. Three- or four-color analyses were performed on either FACScan or FACSCalibur flow cytometers, respectively (BD Biosciences, San Jose, CA). Data analysis of 100,000400,000 live events was performed using FlowJo software (Tree Star, San Carlos, CA). Cell populations were purified by FACS from pooled axillary, inguinal, brachial, and superficial cervical LN to
95% purity at The Wistar Institutes sorting facility using a Cytomation MoFlo and Summit software (Cytomation, Fort Collins, CO).
CFSE labeling
Purified CD4+CD25+ and CD4+CD25- T cells from TS1 x HA28 LN were labeled in vitro with the fluorescent dye CFSE (Molecular Probes, Eugene, OR) as previously described (16). Briefly, purified CD4+CD25+ or CD4+CD25- T cells or unfractionated TS1(SW) LN cells were washed into serum-free IMDM, incubated with 5 mM CFSE at 1 x 107 cells/ml for 4 min, and then incubated with 50% serum. Labeled cells were then washed into serum-free medium for adoptive transfers.
Adoptive transfers
A total of 1.52 x 106 purified CFSE-labeled CD4+CD25+ or CD4+CD25- cells were injected into the tail veins of recipient mice. In some cases, 3 x 106 CFSE-labeled TS1(SW) LN cells were coinjected with the CFSE-labeled CD4+CD25+ or CD4+CD25- T cells. Seven days later, axillary, brachial, inguinal, and superficial cervical LN were harvested from recipient mice and stained for flow cytometry. In some experiments, CFSE-labeled CD4+CD25+ cells were purified by FACS from the LN and spleens of recipient mice and used for in vitro assays.
In vitro proliferation assays
Proliferation assays were performed as previously described (14). Briefly, CFSE-labeled CD4+CD25+ or CD4+CD25- cells from TS1 x HA28 mice were cultured with irradiated BALB/c splenocytes and stimulated with 1 µM S1 peptide in presence or absence of 10 ng/ml IL-2. Four days later, cells were stained for flow cytometry. For suppressor function analysis, 1 x 106 responder TS1 LN cells were cultured with graded numbers of purified cells from TS1 x HA28 mice or from adoptive transfer recipient mice. Cells were stimulated with 0.3 µM S1 peptide in the presence of irradiated BALB/c splenocytes (5 x 106) for 72 h, and then pulsed with 0.5 µCi/well [3H]thymidine and harvested 16 h later.
| Results and Discussion |
|---|
|
|
|---|
TS1 mice express a transgenic TCR specific for the S1 peptide of hemagglutinin that can be detected with the mAb 6.5 (15). We previously showed that interactions with S1 peptide induce 6.5highCD4 single-positive thymocytes to undergo CD25+ regulatory T cell selection in TS1 x HA28 mice, which express S1 in both the thymus and periphery (8, 14). 6.5highCD4+CD25+ regulatory T cells coexist in equal ratios and with equal numbers of 6.5highCD4+CD25- T cells in TS1 x HA28 mice (Fig. 1A; Ref.8). Because signals received from cytokines and self-peptide:MHC complexes can each contribute to the maintenance of conventional CD4+ T cells (1, 4), we were interested in determining how 6.5highCD4+CD25+ regulatory T cells respond to these signals in the periphery. 6.5highCD4+CD25+ T cells from TS1 x HA28 mice expressed lower levels of CD127, the high-affinity receptor for IL-7, than 6.5highCD4+CD25- T cells (Fig. 1B). CD4+CD25+ T cells from BALB/c mice showed similarly reduced levels of CD127 in comparison with CD4+CD25- T cells, excluding the possibility that the low levels of CD127 expression among 6.5highCD4+CD25+ T cells in TS1 x HA28 mice relates to the expression of a transgene-encoded TCR (Fig. 1C). These data are consistent with other studies (12, 17) and suggested that CD4+CD25+ and CD4+CD25- cells could differ in their abilities to respond to lymphopenia, where IL-7 is critical for the homeostatic proliferation of conventional CD4+ T cells (5).
|
To directly examine their abilities to respond to lymphopenia, CD4+CD25+ and CD4+CD25- T cells were purified from LN of TS1 x HA28 mice by cell sorting, labeled with the intracellular dye CFSE, and injected into normal or sublethally irradiated BALB/c mice. We also coinjected a second population of CFSE-labeled LN cells from TS1(SW) mice, which express a TCR specific for an analog of the S1 determinant (termed S1(SW); Ref.8). Seven days later, LN cells were harvested from recipient mice and stained with 6.5 to identify cells from TS1 x HA28 mice or with anti-V
8.3 to identify cells from TS1(SW) mice (8), and the division of the transferred cells was determined based on decreasing CFSE intensity. As expected (2, 4), none of the transferred cell populations divided in nonirradiated BALB/c mice (Fig. 2A). When transferred into lymphopenic BALB/c mice, both the 6.5highCD4+CD25- T cells from TS1 x HA28 mice (which express CD127) and the CD4+V
8+ T cells from TS1(SW) mice underwent one to two rounds of division. However, the 6.5highCD4+CD25+ T cells from TS1 x HA28 mice failed to proliferate in lymphopenic BALB/c mice. The recipient mice were indeed lymphopenic, because the CD4+V
8+ cells that were cotransferred with the 6.5highCD4+CD25+ T cells went through one to two rounds of homeostatic division. Therefore, 6.5highCD4+CD25+ T cells, which express low levels of CD127, do not appear to respond to signals derived from IL-7 or to any other stimuli presented by lymphopenic environments lacking S1 peptide.
|
We next transferred CFSE-labeled CD4+CD25+ or CD4+CD25- cells from TS1 x HA28 mice into normal or sublethally irradiated HA28 mice, and as in BALB/c mice, CFSE-labeled LN cells from TS1(SW) mice were also coinjected. In this case, coinjection of TS1(SW) cells, which have a
100-fold lower affinity for the S1 peptide than 6.5+ cells (8), allowed the specificity of proliferative responses to S1 peptide to be assessed. In contrast to BALB/c mice in which they failed to divide, the 6.5highCD4+CD25+ cells divided up to three times in nonirradiated HA28 mice (Fig. 2A). By contrast, CD4+V
8+ T cells from TS1(SW) mice did not divide in nonirradiated HA28 mice; this, and the failure of 6.5highCD4+CD25+ T cells to divide in BALB/c mice, indicates that the proliferation of 6.5highCD4+CD25+ T cells in HA28 mice is a specific response to S1 peptide (Fig. 2A).
S1 peptide also induced 6.5highCD4+CD25+ T cells to proliferate in lymphopenic HA28 mice (Fig. 2A). In this case, 6.5highCD4+CD25+ T cells divided approximately four to five times, whereas CD4+V
8+ T cells went through one to two rounds of division (similar to their division in lymphopenic BALB/c mice). Interestingly, the expansion of 6.5highCD4+CD25+ T cells in lymphopenic HA28 mice was greater than in nonirradiated HA28 mice, suggesting that their proliferative response to S1 peptide may be enhanced by an increase in space provided by lymphopenia. It is possible that IL-7 signals synergize with TCR signals to enhance proliferation of CD4+CD25+ T cells in lymphopenic HA28 mice, despite the low levels of CD127 that are expressed. However, if this is the case, the ability to respond to IL-7 is nevertheless dependent on interactions with S1 peptide, because these cells did not proliferate in response to lymphopenia alone in BALB/c mice. It is also noteworthy that 6.5highCD4+CD25+ T cells did not suppress the homeostatic proliferation of the cotransferred CD4+V
8+ T cells, as has previously been reported (18, 19). Together with the observations in BALB/c mice, these findings indicate that the peripheral expansion of 6.5highCD4+CD25+ regulatory T cells in HA28 mice is both promoted by and dependent on interactions with the S1 peptide.
We also examined the proliferation of 6.5highCD4+CD25- T cells from TS1 x HA28 mice following transfer into HA28 mice. 6.5highCD4+CD25- T cells proliferated extensively in response to S1 peptide in both nonirradiated and irradiated HA28 mice, in each case going through as many as five divisions (Fig. 2A). Although they express high levels of CD127 and proliferate in lymphopenic BALB/c mice, the ability to respond to IL-7 did not appear to significantly enhance 6.5highCD4+CD25- cell proliferation in lymphopenic vs nonirradiated HA28 mice. The proliferation of CD4+CD25- T cells did not appear to limit the proliferation of the cotransferred CD4+V
8+ T cells in the time period examined, in contrast with recent studies in another system (20). Importantly, the different proliferative capacities of 6.5highCD4+CD25+ and 6.5highCD4+CD25- T cells in response to S1 peptide in HA28 mice correlated well with the abilities of these cells to respond to S1 peptide in vitro where, in the absence of IL-2, 6.5highCD4+CD25+ T cells divided one to two times, whereas 6.5highCD4+CD25- T cells divided four to five times (Ref.14 and Fig. 2B).
Peripheral expansion does not abrogate regulatory function of CD4+CD25+ T cells
To determine whether they retain regulatory function following proliferation in vivo, CD4+CD25+ cells from TS1 x HA28 mice that had undergone division in response to S1 peptide in HA28 mice were reisolated based on CFSE intensity (Fig. 3A). These cells were then examined for their ability to suppress S1-induced in vitro proliferation of TS1 LN cells. CD4+CD25+ cells that had undergone division in vivo were as potent suppressors of proliferation as undivided cells (Fig. 3B). CD4+CD25+ cells were also as potent suppressors as freshly isolated CD4+CD25+ T cells from TS1 x HA28 mice, whereas freshly isolated CD4+CD25- cells from TS1 x HA28 mice did not suppress proliferation of TS1 LN cells. This indicates that CD4+CD25+ T cells retain their regulatory properties following in vivo proliferation, as previously described (13). These data further show that the regulatory CD4+CD25+ cells themselves (and not some other population of CD4+CD25+ cells) undergo division in response to S1 peptide in HA28 mice.
|
In TS1 x HA28 mice, the peptide that mediates the thymic selection of 6.5highCD4+CD25+ T cells is known, and we show in this study that this same peptide can induce the expansion of 6.5highCD4+CD25+ T cells in the periphery. Moreover, the peripheral expansion of 6.5highCD4+CD25+ T cells is dependent on interactions with S1 peptide, because unlike conventional CD4+ T cells (and also 6.5highCD4+CD25- T cells from TS1 x HA28 mice), the 6.5highCD4+CD25+ T cells did not proliferate in response to lymphopenia in BALB/c mice. Several studies have previously demonstrated the proliferation of polyclonal CD4+CD25+ T cells upon transfer into lymphopenic hosts, and some have shown that CD4+CD25+ T cells proliferate in response to Ag administered by immunization or expressed as a self-Ag (12, 13, 17, 18, 20, 21). Our data establish that the ability to proliferate in response to selecting self-peptide:MHC complex, rather than cytokine-derived signals, directs the expansion of CD4+CD25+ T cells in the periphery.
The failure of CD4+CD25+ T cells to proliferate in response to lymphopenia likely reflects the down-modulation of CD127, which is an important cytokine in directing division of conventional CD4+ T cells under lymphopenic conditions. In this respect, it is noteworthy that conventional CD4+ T cells also down-modulate CD127 upon activation, and that CD4+CD25+ regulatory T cells exhibit other phenotypic characteristics, such as increased levels of CTLA-4 and glucocorticoid-induced thymocyte receptor, that they share with activated conventional CD4+ T cells (Refs.22, 23, 24, 25, 26 and data not shown). Whether CD4+CD25+ regulatory T cells exhibit characteristics in common with activated CD4+ T cells as a consequence of high-affinity interactions with self-peptides during their selection in the thymus and/or as a result of ongoing interactions with self-peptides in the periphery remains to be determined. Nevertheless, down-modulation of CD127 on CD4+CD25+ regulatory T cells, coupled with the ability to proliferate in response to their selecting peptide, likely significantly affects how CD4+CD25+ regulatory T cells accumulate in the periphery. 6.5highCD4+CD25+ T cells accumulate in large numbers systemically in TS1 x HA28 mice, because S1 peptide is expressed in a wide variety of tissues (data not shown), and CD4+CD25+ regulatory T cells directed toward ubiquitously expressed bona fide self-Ags are likely to be similarly represented in high numbers and to be systemically distributed. In other cases, CD4+CD25+ T cells that are specific for tissue-restricted Ags proliferated and accumulated selectively in LN draining sites of Ag expression (11, 12, 27). Their differing responsiveness to TCR- vs cytokine-mediated signals provides a mechanism by which CD4+CD25+ T cells specific for tissue-restricted self-Ags (and that may undergo thymic selection via promiscuous expression in thymic epithelial cells (28)) can accumulate selectively at sites of Ag expression, even in lymphopenia.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Andrew J. Caton, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104. E-mail address: caton{at}wistar.upenn.edu ![]()
3 Abbreviations used in this paper: LN, lymph node; int, intermediate. ![]()
Received for publication July 11, 2003. Accepted for publication October 10, 2003.
| References |
|---|
|
|
|---|
chain expression in activated T lymphocytes. Proc. Natl. Acad. Sci. USA 99:13759.This article has been cited by other articles:
![]() |
B. Blanco, J. A. Perez-Simon, L. I. Sanchez-Abarca, T. Caballero-Velazquez, S. Gutierrez-Cossio, P. Hernandez-Campo, M. Diez-Campelo, C. Herrero-Sanchez, C. Rodriguez-Serrano, C. Santamaria, et al. Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population Haematologica, July 1, 2009; 94(7): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fudaba, T. Onoe, M. Chittenden, A. Shimizu, J. M. Shaffer, R. Bronson, and M. Sykes Abnormal Regulatory and Effector T Cell Function Predispose to Autoimmunity following Xenogeneic Thymic Transplantation J. Immunol., December 1, 2008; 181(11): 7649 - 7659. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamazaki, D. Dudziak, G. F. Heidkamp, C. Fiorese, A. J. Bonito, K. Inaba, M. C. Nussenzweig, and R. M. Steinman CD8+CD205+ Splenic Dendritic Cells Are Specialized to Induce Foxp3+ Regulatory T Cells J. Immunol., November 15, 2008; 181(10): 6923 - 6933. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hao, J. Yuan, S. Xu, M. A. Munegowda, Y. Deng, J. Gordon, Z. Xing, and J. Xiang Antigen Specificity Acquisition of Adoptive CD4+ Regulatory T Cells via Acquired Peptide-MHC Class I Complexes J. Immunol., August 15, 2008; 181(4): 2428 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Tang, J. R. Teijaro, M. N. Njau, S. S. Chandran, A. Azimzadeh, S. G. Nadler, D. M. Rothstein, and D. L. Farber CTLA4 Expression Is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis J. Immunol., August 1, 2008; 181(3): 1806 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Boyman, C. Ramsey, D. M. Kim, J. Sprent, and C. D. Surh IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia J. Immunol., June 1, 2008; 180(11): 7265 - 7275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fernandez, F. K. Puttur, Y. M. Wang, W. Howden, S. I. Alexander, and C. A. Jones T Regulatory Cells Contribute to the Attenuated Primary CD8+ and CD4+ T Cell Responses to Herpes Simplex Virus Type 2 in Neonatal Mice J. Immunol., February 1, 2008; 180(3): 1556 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Siewert, U. Lauer, S. Cording, T. Bopp, E. Schmitt, A. Hamann, and J. Huehn Experience-Driven Development: Effector/Memory-Like {alpha}E+Foxp3+ Regulatory T Cells Originate from Both Naive T Cells and Naturally Occurring Naive-Like Regulatory T Cells J. Immunol., January 1, 2008; 180(1): 146 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chappert, M. Leboeuf, P. Rameau, D. Stockholm, R. Liblau, O. Danos, J. M. Davoust, and D.-A. Gross Antigen-Driven Interactions with Dendritic Cells and Expansion of Foxp3+ Regulatory T Cells Occur in the Absence of Inflammatory Signals J. Immunol., January 1, 2008; 180(1): 327 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Li, N. Perez, S. Karumuthil-Melethil, B. S. Prabhakar, M. J. Holterman, and C. Vasu Enhanced Engagement of CTLA-4 Induces Antigen-Specific CD4+CD25+Foxp3+ and CD4+CD25 TGF-beta1+ Adaptive Regulatory T Cells J. Immunol., October 15, 2007; 179(8): 5191 - 5203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hao, Y. Liu, J. Yuan, X. Zhang, T. He, X. Wu, Y. Wei, D. Sun, and J. Xiang Novel Exosome-Targeted CD4+ T Cell Vaccine Counteracting CD4+25+ Regulatory T Cell-Mediated Immune Suppression and Stimulating Efficient Central Memory CD8+ CTL Responses J. Immunol., September 1, 2007; 179(5): 2731 - 2740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kapp, K. Honjo, L. M. Kapp, K. Goldsmith, and R. P. Bucy Antigen, in the Presence of TGF-beta, Induces Up-Regulation of FoxP3gfp+ in CD4+ TCR Transgenic T Cells That Mediate Linked Suppression of CD8+ T Cell Responses J. Immunol., August 15, 2007; 179(4): 2105 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Codarri, L. Vallotton, D. Ciuffreda, J.-P. Venetz, M. Garcia, K. Hadaya, L. Buhler, S. Rotman, M. Pascual, and G. Pantaleo Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7R{alpha}high cell population in solid organ transplant recipients J. Exp. Med., July 9, 2007; 204(7): 1533 - 1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Stephens, J. Andersson, and E. M. Shevach Distinct Subsets of FoxP3+ Regulatory T Cells Participate in the Control of Immune Responses J. Immunol., June 1, 2007; 178(11): 6901 - 6911. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Bayer, A. Yu, and T. R. Malek Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T Regulatory Cells J. Immunol., April 1, 2007; 178(7): 4062 - 4071. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Steptoe, J. M. Ritchie, N. S. Wilson, J. A. Villadangos, A. M. Lew, and L. C. Harrison Cognate CD4+ Help Elicited by Resting Dendritic Cells Does Not Impair the Induction of Peripheral Tolerance in CD8+ T Cells J. Immunol., February 15, 2007; 178(4): 2094 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tellier, J. P. M. van Meerwijk, and P. Romagnoli An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes Int. Immunol., November 1, 2006; 18(11): 1509 - 1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yu and T. R. Malek Selective Availability of IL-2 Is a Major Determinant Controlling the Production of CD4+CD25+Foxp3+ T Regulatory Cells J. Immunol., October 15, 2006; 177(8): 5115 - 5121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bourgeois and B. Stockinger CD25+CD4+ Regulatory T Cells and Memory T Cells Prevent Lymphopenia-Induced Proliferation of Naive T Cells in Transient States of Lymphopenia J. Immunol., October 1, 2006; 177(7): 4558 - 4566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Ford, Z.-X. Zhang, W. Chen, and L. Zhang Double-Negative T Regulatory Cells Can Develop Outside the Thymus and Do Not Mature from CD8+ T Cell Precursors. J. Immunol., September 1, 2006; 177(5): 2803 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rezvani, S. Mielke, M. Ahmadzadeh, Y. Kilical, B. N. Savani, J. Zeilah, K. Keyvanfar, A. Montero, N. Hensel, R. Kurlander, et al. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT Blood, August 15, 2006; 108(4): 1291 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S. I. Alexander, R. Nanan, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells J. Exp. Med., July 10, 2006; 203(7): 1693 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baecher-Allan, E. Wolf, and D. A. Hafler MHC class II expression identifies functionally distinct human regulatory T cells. J. Immunol., April 15, 2006; 176(8): 4622 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani Regulatory T Cells Are Expanded in Blood and Disease Sites in Patients with Tuberculosis Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. de Kleer, B. Vastert, M. Klein, G. Teklenburg, G. Arkesteijn, G. P. Yung, S. Albani, W. Kuis, N. Wulffraat, and B. Prakken Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network Blood, February 15, 2006; 107(4): 1696 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Setiady, K. Ohno, E. T. Samy, H. Bagavant, H. Qiao, C. Sharp, J. X. She, and K. S. K. Tung Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+CD25+ regulatory T cells Blood, February 1, 2006; 107(3): 1056 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skapenko, J. R. Kalden, P. E. Lipsky, and H. Schulze-Koops The IL-4 Receptor {alpha}-Chain-Binding Cytokines, IL-4 and IL-13, Induce Forkhead Box P3-Expressing CD25+CD4+ Regulatory T Cells from CD25-CD4+ Precursors J. Immunol., November 1, 2005; 175(9): 6107 - 6116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P Hickman and L. A Turka Homeostatic T cell proliferation as a barrier to T cell tolerance Phil Trans R Soc B, September 29, 2005; 360(1461): 1713 - 1721. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Samy, L. A. Parker, C. P. Sharp, and K. S.K. Tung Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node J. Exp. Med., September 19, 2005; 202(6): 771 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lundsgaard, T. L. Holm, L. Hornum, and H. Markholst In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells Expressing Foxp3 Diabetes, April 1, 2005; 54(4): 1040 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schenk, D. D. Kish, C. He, T. El-Sawy, E. Chiffoleau, C. Chen, Z. Wu, S. Sandner, A. V. Gorbachev, K. Fukamachi, et al. Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells J. Immunol., March 15, 2005; 174(6): 3741 - 3748. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Bayer, A. Yu, D. Adeegbe, and T. R. Malek Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period J. Exp. Med., March 7, 2005; 201(5): 769 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Antony, C. A. Piccirillo, A. Akpinarli, S. E. Finkelstein, P. J. Speiss, D. R. Surman, D. C. Palmer, C.-C. Chan, C. A. Klebanoff, W. W. Overwijk, et al. CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells J. Immunol., March 1, 2005; 174(5): 2591 - 2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Wang, G. Peng, Z. Guo, E. M. Shevach, and R.-F. Wang Recognition of a New ARTC1 Peptide Ligand Uniquely Expressed in Tumor Cells by Antigen-Specific CD4+ Regulatory T Cells J. Immunol., March 1, 2005; 174(5): 2661 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hanash and R. B. Levy Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation Blood, February 15, 2005; 105(4): 1828 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Turk, J. A. Guevara-Patino, G. A. Rizzuto, M. E. Engelhorn, and A. N. Houghton Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells J. Exp. Med., September 20, 2004; 200(6): 771 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lerman, J. Larkin III, C. Cozzo, M. S. Jordan, and A. J. Caton CD4+ CD25+ Regulatory T Cell Repertoire Formation in Response to Varying Expression of a neo-Self-Antigen J. Immunol., July 1, 2004; 173(1): 236 - 244. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |